Idorsia Ltd (SWX:IDIA)
Switzerland · Delayed Price · Currency is CHF 3.695
-0.170 (-4.40%)
Feb 20, 2026, 5:31 PM CET
Idorsia Market Cap
Idorsia has a market cap or net worth of 972.07 million as of February 20, 2026. Its market cap has increased by 627.45% in one year.
Market Cap
972.07M
Enterprise Value
2.17B
Revenue
232.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.70
Market Cap Chart
Since June 16, 2017, Idorsia's market cap has decreased from 1.63B to 972.07M, a decrease of -40.22%. That is a compound annual growth rate of -5.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 972.07M | -8.53% |
| Dec 30, 2025 | 1.06B | 586.49% |
| Dec 30, 2024 | 154.81M | -58.92% |
| Dec 29, 2023 | 376.84M | -84.18% |
| Dec 30, 2022 | 2.38B | -27.77% |
| Dec 30, 2021 | 3.30B | -22.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Basilea Pharmaceutica AG | 675.85M |
| Newron Pharmaceuticals | 420.31M |
| Santhera Pharmaceuticals Holding AG | 237.86M |
| BioVersys AG | 137.43M |
| Molecular Partners AG | 136.69M |
| Xlife Sciences AG | 117.66M |
| EvoNext Holdings | 6.20M |
| Addex Therapeutics | 5.67M |